Loading...
Loading...
GSK| Name | Value |
|---|---|
| Revenues | 7,376.0M |
| Cost of Revenue | 2,238.0M |
| Gross Profit | 5,138.0M |
| Operating Expense | 3,270.0M |
| Operating I/L | 1,868.0M |
| Other Income/Expense | -242.0M |
| Interest Income | 26.0M |
| Pretax | 1,626.0M |
| Income Tax Expense | 1.0M |
| Net Income/Loss | 1,495.0M |
GSK plc is a pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products globally. The company operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare, offering a diverse portfolio of medicines in therapeutic areas such as respiratory, HIV, oncology, and cardiovascular, as well as consumer healthcare products in wellness, oral health, nutrition, and skin health categories. GSK plc generates revenue through the sale of its pharmaceutical and consumer healthcare products, including nasal sprays, tablets, syrups, toothpastes, and topical creams.
